Ofienza-M

Although an extra dose of Ofienza-M Syrup Mango will not have any side effects, you must always be vigilant. If you think you have given too much Ofienza-M Syrup Mango to your child, immediately speak to a doctor. Overdose increases the risk of unwanted side effects such as seizures, tremors, severe headache, sudden weakness, blood cell abnormalities, and rapid and irregular heartbeat. Rush to your child’s doctor on an immediate basis if you notice any of these symptoms.

Ineffective treatment with Ofienza-M Syrup Mango could mean that the medicine is not able to act against the infection-causing bacteria. In such a case, visit your child’s doctor who may prescribe some other antibiotic, having more specific action toward the infection-causing bacteria.

Ofienza-M Syrup Mango can sometimes interact with other medicines or substances. Tell your doctor about any other medicines your child is taking before starting Ofienza-M Syrup Mango. Also, check with your child’s doctor before giving any medicine to your child.

Antibiotics usually do not interfere with the ingredients in vaccines or cause a bad reaction in a child who has just been vaccinated. However, children taking antibiotics should not get vaccinated until they recover from the illness. As soon as your child feels better, the vaccine can be given.

Inform the doctor if your child is suffering from heart disease, genetic disorders involving blood vessels, seizures, psychiatric disorders, diabetes, photoallergy (allergy from sunlight), neuromuscular disorders, or rheumatoid arthritis. This is because there is a possibility that Ofienza-M Syrup Mango may aggravate these conditions and result in complications.

Yes, it is normal. Ofienza-M Syrup Mango contains an active ingredient called metronidazole which can cause red-brown urine. It is a harmless side effect. It will subside once the medicine is stopped after the completion of the treatment.

No, do not give Ofienza-M Syrup Mango with cough and cold medicines as it can interfere with their working.